Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival

AIM: To evaluate outcomes of radiofrequency ablation (RFA) therapy for early hepatocellular carcinoma (HCC) and identify survival- and recurrence-related factors. METHODS: Consecutive patients diagnosed with early HCC by computed tomography (CT) or magnetic resonance imaging (MRI) (single nodule of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kikuchi, Luciana, Menezes, Marcos, Chagas, Aline L, Tani, Claudia M, Alencar, Regiane SSM, Diniz, Marcio A, Alves, Venâncio AF, D’Albuquerque, Luiz Augusto Carneiro, Carrilho, Flair José
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Co., Limited 2014
Materias:
Brief Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3925868/
https://ncbi.nlm.nih.gov/pubmed/24587635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i6.1585
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares